kids have obesity
Health Canada has consistently flagged compounded retatrutide as outside permitted activity given the absence of any authorized retatrutide product
Odegard PS, Setter SM, Neumiller JJ
Full Phase 3 trial data will be required before definitive conclusions can be drawn
Nevertheless, even the most effective marketed incretin, the GLP-1/GIP dual agonist tirzepatide, produces a maximum HbA1c reduction of ~2.6%, with fewer than half of participants in the SURPASS trials reaching normoglycemia (HbA1c 10%), vehicle-treated animals lost ~40% of body weight over 3 months, consistent with prior reports showing comparable reductions from ~40 g at week 10 to ~25 g by week 20 19
If you quit, you lose the cost of medication already used, time invested, and have to start over if you try again later